tirzepatide lawsuits Lilly asks to join lawsuit over compounded versions of its weight-loss drugs Oral Tirzepatide Class Action Lawsuit

Since the FDA approved Ozempic in 2017, the drugs manufacturer, Novo Nordisk, has not included warnings that the medication can cause gastroparesis in its prescription information

Numerous studies have provided evidence for histological and functional improvements in rodent models of Alzheimers, Parkinsons and other neurodegenerative diseases

Similar to our findings, a study with glucose-lowering using liraglutide, sulfonylurea and/or insulin showed a reduction in renal parenchyma volume in patients with type 2 diabetes after 26 weeks of treatment

PMID 28032115

For consultation please visit our website:

Human enzymes cannot digest plant cells, says Daniell